About
Specializes in issues related to responsible knowledge-based decision-making with focus on risk and safety of medicines, both from a practical, methodological and philosophical perspective. Works interdisciplinary between scientific evidence, practice, policy and philosophy. Research includes causality assessment in drug safety, clinical reasoning, analysis of expert disagreement.
Fields of study
Academic disciplines
Philosophy Other subjects within philosophy Medical immunology
Research groups
Research projects
Ongoing research projects
-
Causality, complexity and evidence in pharmacovigilance
Detecting unknown adverse reactions of marketed medicines is challenging and needs improved methods to assess causality, as well as improved quality of clinical observations.
Publications and research
Scientific publications
Andersen, Fredrik ; Anjum, Rani Lill; Rocca, Elena (2025). When Decisions Must be Based on Partial Causal Knowledge: Analyzing Causality and Evidence for Health Policy. illary, phyllis; Russo, Federica (Ed.). The Routledge Handbook of Causality and Causal Methods . p. 493-506. Routledge.
Anjum, Rani Lill; Price, Christine;
Rocca, Elena
(2024).
When Patient Voices Get Lost in Evidence Hierarchies: A Testimony of Rare Adverse Events and Participatory Epistemic Injustice in Drug Safety Monitoring.
14 p.
Social Epistemology.
https://doi.org/10.1080/02691728.2024.2400079
Leblanc, Marissa Erin; Williamson, Jon; De Pretis, Francesco; Landes, Jurgen;
Rocca, Elena
(2024).
Individual consent in cluster randomised trials for non-pharmaceutical interventions: going beyond the Ottawa statement.
9 p.
Critical Public Health.
Vol. 34.
https://doi.org/10.1080/09581596.2024.2338074
Anjum, Rani Lill;
Rocca, Elena
(2024).
A Dispositional Account of Causation: Implications for the Biological Sciences.
Yafeng, Shan; Shan, Yafeng (Ed.).
Alternative Approaches to Causation: Beyond Difference-Making and Mechanism. p. 95-121.
Oxford University Press.
https://doi.org/https://doi.org/10.1093/oso/978019
Anjum, Rani Lill; Chandler, Rebecca;
Rocca, Elena
(2022).
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets.
8 p.
Pharmaceutical Medicine.
Vol. 36.
https://doi.org/10.1007/s40290-022-00429-9
Pérez-González, Saul;
Rocca, Elena
(2022).
Evidence of Biological Mechanisms and Health Predictions: An Insight into Clinical Reasoning.
16 p.
Perspectives in biology and medicine.
Vol. 65.
https://doi.org/10.1353/pbm.2022.0005
Rocca, Elena
; Grundmark, Birgitta
(2021).
Monitoring the Safety of Medicines and Vaccines in Times of Pandemic: Practical, Conceptual, and Ethical Challenges in Pharmacovigilance.
19 p.
Argumenta.
Vol. 7.
https://doi.org/10.14275/2465-2334/202113.roc
Rocca, Elena
; Gauffin, Oskar; Savage, Ruth; Vidlin, Sara Hedfors; Grundmark, Birgitta
(2021).
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
Drug Safety.
Vol. 44.
https://doi.org/10.1007/s40264-021-01091-x
Rocca, Elena
; Anjum, Rani Lill
(2020).
Erice Call for Change: Utilising Patient Experiences to Enhance the Quality and Safety of Healthcare.
Drug Safety.
Vol. 43.
https://doi.org/10.1007/s40264-020-00919-2
Rocca, Elena
(2020).
Probability for the Clinical Encounter.
Anjum, Rani Lill; Copeland, Samantha Marie; Rocca, Elena (Ed.).
Rethinking Causality, Complexity and Evidence for the Unique Patient. A CauseHealth Resource for Healthcare Professionals and the Clinical Encounter. p. 37-54.
Springer Nature.
https://doi.org/10.1007/978-3-030-41239-5_3
